Fetal Genetic Variants Implicated in Spontaneous Preterm Birth Risk
|
By LabMedica International staff writers Posted on 03 Jul 2019 |

Image: The UltraClean BloodSpin DNA Isolation Kit is designed to isolate genomic and mitochondrial DNA from whole blood (fresh, frozen or stored at 4 °C), buffy coat or cultured cells (Photo courtesy of MO BIO Laboratories).
Preterm live births that take place before 37 completed weeks of gestation and even as early as 22–24 weeks are a global problem. Up to 11.1% (15 million babies) of all births worldwide occur prematurely, and approximately 45% to 50% of them are idiopathic or spontaneous.
Many pathways and cellular processes are reported to be associated with Spontaneous Preterm Birth (SPTB), including response to infection, regulation of inflammation, stress, and other immunologically mediated processes. A gene has been identified involved in axon guidance, neuronal migration, and inflammation, that appear to coincide with spontaneous preterm birth.
An international team of Finnish and American scientists led by the Oulu University Hospital (Oulu, Finland) studied a population that included 260 SPTB cases (139 male and 121 female infants) and 9,630 controls (4,055 males and 5,575 females). The cases were very preterm infants born between 25 and 30 weeks of gestation and were clinically defined as SPTB in 2005–2008. In the Finnish cohorts, SPTB was defined as birth occurring after spontaneous onset of labor at <36 completed weeks + 1 day of gestation.
Umbilical cord blood, umbilical cord tissue, or saliva was obtained from the study subjects. Commercial kits were used to extract genomic DNA from blood, or Puregene Blood Core Kit and cord tissue using Qiagen’s Gentra Puregene Tissue Kit. Genome-wide SNP genotyping was performed with the Infinium HumanCoreExome BeadChip. In total, 18 placental samples were analyzed by immunohistochemistry.
The team reported that after replication testing in hundreds more babies born particularly prematurely and thousands of control infants, they were left with a single nucleotide polymorphism (SNP) in the SLIT2 gene that was significantly associated with spontaneous preterm birth, as well as suggestive associations for SNPs in other axon guidance genes. The team's follow-up gene expression, localization, and functional experiments indicated that SLIT2 and ROBO1, which encodes SLIT2's receptor protein, are expressed at higher-than-usual levels in certain parts of the placenta for infants experiencing spontaneous preterm birth.
The most significant association with spontaneous birth involved a SNP called rs116461311 in SLIT2, prompting a series of immunohistochemistry, qRT-PCR, and gene silencing experiments on placental samples or cells that the scientists used to decode SLIT2-ROBO1 interactions and their consequences for birth timing. The authors concluded that based on the currently available evidence they propose that activation of SLIT2-ROBO1 expression and signaling in [placental] trophoblast cells contributes to inflammatory and immune activation, which in turn leads to early labor and preterm birth. The study was published on June 13, 2019, in the journal PLOS Genetics.
Related Links:
Oulu University Hospital
Many pathways and cellular processes are reported to be associated with Spontaneous Preterm Birth (SPTB), including response to infection, regulation of inflammation, stress, and other immunologically mediated processes. A gene has been identified involved in axon guidance, neuronal migration, and inflammation, that appear to coincide with spontaneous preterm birth.
An international team of Finnish and American scientists led by the Oulu University Hospital (Oulu, Finland) studied a population that included 260 SPTB cases (139 male and 121 female infants) and 9,630 controls (4,055 males and 5,575 females). The cases were very preterm infants born between 25 and 30 weeks of gestation and were clinically defined as SPTB in 2005–2008. In the Finnish cohorts, SPTB was defined as birth occurring after spontaneous onset of labor at <36 completed weeks + 1 day of gestation.
Umbilical cord blood, umbilical cord tissue, or saliva was obtained from the study subjects. Commercial kits were used to extract genomic DNA from blood, or Puregene Blood Core Kit and cord tissue using Qiagen’s Gentra Puregene Tissue Kit. Genome-wide SNP genotyping was performed with the Infinium HumanCoreExome BeadChip. In total, 18 placental samples were analyzed by immunohistochemistry.
The team reported that after replication testing in hundreds more babies born particularly prematurely and thousands of control infants, they were left with a single nucleotide polymorphism (SNP) in the SLIT2 gene that was significantly associated with spontaneous preterm birth, as well as suggestive associations for SNPs in other axon guidance genes. The team's follow-up gene expression, localization, and functional experiments indicated that SLIT2 and ROBO1, which encodes SLIT2's receptor protein, are expressed at higher-than-usual levels in certain parts of the placenta for infants experiencing spontaneous preterm birth.
The most significant association with spontaneous birth involved a SNP called rs116461311 in SLIT2, prompting a series of immunohistochemistry, qRT-PCR, and gene silencing experiments on placental samples or cells that the scientists used to decode SLIT2-ROBO1 interactions and their consequences for birth timing. The authors concluded that based on the currently available evidence they propose that activation of SLIT2-ROBO1 expression and signaling in [placental] trophoblast cells contributes to inflammatory and immune activation, which in turn leads to early labor and preterm birth. The study was published on June 13, 2019, in the journal PLOS Genetics.
Related Links:
Oulu University Hospital
Latest Molecular Diagnostics News
- Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation
- Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth
- Liquid Biopsy Combines Multiple Signals for Cancer Detection in a Single Analysis
- Newborn Screening Program Adds Spinal Muscular Atrophy Testing Across England
- Blood Test Could Help Fast-Track Lymphoma Diagnosis in Resource-Limited Settings
- Liquid Biopsy Assay Enriches Tumor DNA for Early Detection and Monitoring
- Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy
- Point-of-Care Multiplex PCR Test Submitted to FDA for Flu A/B and RSV Detection
- New PCR Assays Expand Cyclospora Testing for Outbreak Surveillance
- Single Liquid Biopsy Predicts Early Immunotherapy Benefit in Advanced Lung Cancer
- Machine Learning Tool Improves Prediction of Liver Cancer Recurrence
- AI-Powered Liquid Biopsy Detects Liver Cancer Across Diverse Populations
- Circular RNAs Enable Noninvasive Cancer Detection and Risk Assessment
- Polygenic Risk Score Test Estimates Inherited Coronary Artery Disease Risk
- AI Tool Improves Long-Read Detection of Cancer Mutations
- FDA Clears Molecular Test for Bacterial Vaginosis and Candida Vaginitis
Channels
Clinical Chemistry
view channel
Blood Metabolite Patterns May Enable Early Detection of Blood-Brain Barrier Injury
Early injury to the blood-brain barrier (BBB) can precede many neurological disorders but remains difficult to detect noninvasively. Laboratory markers that identify barrier dysfunction before symptoms... Read more
Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease
Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read moreHematology
view channel
New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome
Inherited bone marrow failure syndromes (IBMFS) impair the bone marrow’s ability to produce sufficient healthy blood cells and are associated with an increased risk of early-onset myelodysplastic syndromes (MDS).... Read more
Ultra-Portable Device Enables Finger-Prick Blood Testing at Home
Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. In the UK, millions of tests are performed each year to diagnose disease, guide therapy,... Read moreImmunology
view channel
Immune Biomarkers May Predict Recurrent Checkpoint Inhibitor Arthritis
Inflammatory arthritis is a recognized immune-related adverse event in patients treated with immune checkpoint inhibitors (ICIs) for cancer. Between 20% and 50% of affected patients experience more than... Read more
Immune Cell Blood Test May Predict Melanoma Immunotherapy Response
Melanoma remains one of the deadliest skin cancers, although outcomes improve markedly when the disease is detected early. Immunotherapy has extended survival for many patients with advanced melanoma,... Read moreMicrobiology
view channel
Surveillance and Susceptibility Testing Track Rising Candida Auris in U.S.
Drug-resistant fungal infections are straining infection control and treatment in hospitals and long-term care facilities, where rapid transmission can lead to severe outcomes. Candida auris has expanded... Read more
Plasma Cell-Free DNA Test Enables Earlier Diagnosis of Invasive Fungal Infections
Invasive fungal infections disproportionately affect immunocompromised patients, while diagnostic delays can contribute to substantial morbidity and mortality. Existing methods often depend on invasive... Read morePathology
view channel
AI Uses H&E Slides to Predict Key Biomarkers Across 32 Cancers
Molecular profiling is essential for characterizing solid tumors, but many laboratories still rely on separate genetic assays to detect alterations such as TP53 mutations. These workflows can be resource-intensive... Read more
AI Tool Identifies Slide Artifacts to Speed Digital Pathology Diagnosis
Pathology laboratories face growing case volumes, staffing pressures, and increasing diagnostic complexity that can delay results. At the same time, whole-slide images may contain quality defects such... Read more
FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis
Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read moreTechnology
view channel
Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results
Proteotype Diagnostics has introduced Alchemi, a proprietary data and clinical workflow platform being developed for Enlighten, the company’s investigational blood-based multi-cancer test.... Read more
Training Device Improves Accuracy of Pooled Molecular Diagnostics
High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. Sample pooling can cut per‑test... Read more
New CE-Certified Software Advances Whole-Genome Cancer Testing
European hospitals are increasingly using comprehensive tumor genomics to guide therapy, but routine whole genome sequencing (WGS) requires validated, regulation-compliant workflows. A newly CE-certified... Read more
National Rare Disease Registry Standardizes Genetic and Clinical Data for Coordinated Care
Rare diseases collectively impose a significant clinical burden despite their individual rarity, often involving multisystem presentations and prolonged diagnostic journeys. Limited specialist expertise... Read moreIndustry
view channel
Collaboration Supports Global ADC Development with AI-Powered Tissue Analysis
Selecting patients for antibody-drug conjugates (ADCs) increasingly requires broader tissue context, as target expression alone may not fully explain therapeutic response. Laboratories and translational... Read more
Standardized Staining Technology Advances Digital Pathology Workflows
Digital pathology is increasingly used to streamline cancer diagnostics, yet staining variability can hinder slide interpretation and limit the reliability of artificial intelligence tools.... Read more
Global Testing Service Advances Leukemia MRD Monitoring
KMT2A rearrangements drive aggressive subsets of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and are associated with relapse and poor outcomes. As menin inhibitors enter clinical... Read more





.jpg)

